NCT06407817 Comparative Effects Of Spencer and Reverse Distraction Technique In Patients With Adhesive Capsulitis
| NCT ID | NCT06407817 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Adhesive Capsulitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2025-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-02-01 with a primary completion date of 2025-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the effects of spencer and reverse distraction technique in patients with adhesive capsulitis
Eligibility Criteria
Inclusion Criteria: * Age group 40-60 years * Male and female * Positive Capsular pattern (ER more limited than Abd which is more limited than IR) * Limitation in shoulder ROM ; Flexion \<180 , Abduction \<180 , External Rotation \<50 * Patients of stage 2 and 3 of adhesive capsulitis Exclusion Criteria: * History of surgery of the affected shoulder * Fractures in around the shoulder * Neurological disorders leading to altered muscle activity * Systemic arthritic conditions (RA, Osteoporosis) * Disorders of the cervical spine
Contact & Investigator
Rabiya Noor, PHD
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06407817 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06407817 currently recruiting?
Yes, NCT06407817 is actively recruiting participants. Contact the research team at minalmustafakhan@gmail.com for enrollment information.
Where is the NCT06407817 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06407817 clinical trial?
NCT06407817 is sponsored by Riphah International University. The principal investigator is Rabiya Noor, PHD at Riphah International University. The trial plans to enroll 50 participants.